BACKGROUND: Revascularization for the treatment of coronary artery disease (CAD) is advancing rapidly and is used increasingly in old patients. This study aimed to compare the efficacy and safety of revascularization with drug therapy in CAD patients aged over 80 years at a real-world clinical setting. METHODS: A total of 501 CAD patients aged over 80 years were consecutively enrolled from January 2011 to January 2016 in Anzhen Hospital (Beijing, China), Capital Medical University. The patients were treated with percutaneous coronary intervention (PCI) (n=283), coronary artery bypass grafting (CABG) (n=106), or drug therapy (n=112). All-cause mortality, cardiovascular-related mortality, readmission rate, and Seattle Angina Questionnaire (SAQ) score were compared between the three treatment methods. RESULTS: A total of 411 patients (82.04%) were followed with a median duration of 25 months. All-cause mortality and cardiovascular-related mortality in the drug therapy group were significantly higher than the PCI and CABG groups (both P<0.05). Readmission rate for cardiovascular events in the CABG group was significantly lower than the PCI and drug therapy groups (both P<0.05). Scores of physical limitation, angina frequency, treatment satisfaction, and disease perception of the SAQ in the PCI and CABG groups were significantly higher than the drug therapy group (both P<0.05). Scores of angina stability did not differ significant between the three groups (P=0.127). CONCLUSIONS: Revascularization is superior to drug therapy in efficacy and safety in the treatment of oldest-old patients with CAD. 2020 Cardiovascular Diagnosis and Therapy. All rights reserved.
BACKGROUND: Revascularization for the treatment of coronary artery disease (CAD) is advancing rapidly and is used increasingly in old patients. This study aimed to compare the efficacy and safety of revascularization with drug therapy in CAD patients aged over 80 years at a real-world clinical setting. METHODS: A total of 501 CAD patients aged over 80 years were consecutively enrolled from January 2011 to January 2016 in Anzhen Hospital (Beijing, China), Capital Medical University. The patients were treated with percutaneous coronary intervention (PCI) (n=283), coronary artery bypass grafting (CABG) (n=106), or drug therapy (n=112). All-cause mortality, cardiovascular-related mortality, readmission rate, and Seattle Angina Questionnaire (SAQ) score were compared between the three treatment methods. RESULTS: A total of 411 patients (82.04%) were followed with a median duration of 25 months. All-cause mortality and cardiovascular-related mortality in the drug therapy group were significantly higher than the PCI and CABG groups (both P<0.05). Readmission rate for cardiovascular events in the CABG group was significantly lower than the PCI and drug therapy groups (both P<0.05). Scores of physical limitation, angina frequency, treatment satisfaction, and disease perception of the SAQ in the PCI and CABG groups were significantly higher than the drug therapy group (both P<0.05). Scores of angina stability did not differ significant between the three groups (P=0.127). CONCLUSIONS: Revascularization is superior to drug therapy in efficacy and safety in the treatment of oldest-old patients with CAD. 2020 Cardiovascular Diagnosis and Therapy. All rights reserved.
Authors: Cheuk-Kit Wong; L Kristin Newby; Manju V Bhapker; Phil E Aylward; Matthias Pfisterer; Karen P Alexander; Paul W Armstrong; Judith S Hochman; Frans Van de Werf; Robert M Califf; Harvey D White Journal: Am Heart J Date: 2007-08 Impact factor: 4.749
Authors: Matthias Pfisterer; Peter Buser; Stefan Osswald; Urs Allemann; Wolfgang Amann; Walter Angehrn; Eric Eeckhout; Paul Erne; Werner Estlinbaum; Gabriela Kuster; Tiziano Moccetti; Barbara Naegeli; Peter Rickenbacher Journal: JAMA Date: 2003-03-05 Impact factor: 56.272
Authors: W B Batchelor; K J Anstrom; L H Muhlbaier; R Grosswald; W S Weintraub; W W O'Neill; E D Peterson Journal: J Am Coll Cardiol Date: 2000-09 Impact factor: 24.094
Authors: Michelle M Graham; William A Ghali; Peter D Faris; P Diane Galbraith; Colleen M Norris; Merril L Knudtson Journal: Circulation Date: 2002-05-21 Impact factor: 29.690
Authors: Gregg W Stone; Judith S Hochman; David O Williams; William E Boden; T Bruce Ferguson; Robert A Harrington; David J Maron Journal: J Am Coll Cardiol Date: 2015-11-23 Impact factor: 24.094
Authors: Donald S Likosky; Lawrence J Dacey; Yvon R Baribeau; Bruce J Leavitt; Robert Clough; Richard P Cochran; Reed Quinn; Donato A Sisto; David C Charlesworth; David J Malenka; Todd A MacKenzie; Elaine M Olmstead; Cathy S Ross; Gerald T O'Connor Journal: Ann Thorac Surg Date: 2008-04 Impact factor: 4.330
Authors: Victor M G Legrand; Patrick W Serruys; Felix Unger; Ben A van Hout; Mathias C M Vrolix; Geert M P Fransen; Torsten Toftegaard Nielsen; Peter Kildeberg Paulsen; Ricardo Seabra Gomes; João M G de Queiroz e Melo; José P Marques dos Santos Neves; Wietze Lindeboom; Bianca Backx Journal: Circulation Date: 2004-03-01 Impact factor: 29.690
Authors: Karen P Alexander; L Kristin Newby; Paul W Armstrong; Christopher P Cannon; W Brian Gibler; Michael W Rich; Frans Van de Werf; Harvey D White; W Douglas Weaver; Mary D Naylor; Joel M Gore; Harlan M Krumholz; E Magnus Ohman Journal: Circulation Date: 2007-05-15 Impact factor: 29.690
Authors: Emma Miranda Malpica; Marco Antonio Peña Duque; José Castellanos; Emilio Exaire; Oscar Arrieta; Eduardo Salazar Dávila; Ramón Villavicencio Fernández; Hilda Delgadillo-Rodríguez; Carlos J González-Quesada; Marco A Martínez-Ríos Journal: Arch Cardiol Mex Date: 2007 Jul-Sep